MedTrace Logo

Genomic Sequencing in Patients With HCM Undergoing Septal Myectomy

NCT03043209 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-01-06

No results posted yet for this study

Summary

Investigators aim to use comparative exome and/or genome sequencing to discover causative molecular lesions for phenotypes hypothesized to be caused by somatic mutations. For this study, investigators have targeted hypertrophic cardiomyopathy.

Conditions

Interventions

GENETIC

Genomic sequencing

Genomic sequencing of DNA in Blood sample and myectomy tissue

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Milind Desai, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-30
Primary Completion
2020-12-04
Completion
2022-12-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03043209 on ClinicalTrials.gov